​

AC Immune SA (ACIU) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ACIU Stock Forecast

AC Immune SA (ACIU) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $10.00 and a low of $8.00. This represents a 240.91% increase from the last price of $2.64.

$2 $3 $4 $5 $6 $7 $8 $9 $10 High: $10 Avg: $9 Low: $8 Last Closed Price: $2.64

ACIU Stock Rating

AC Immune SA stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

ACIU Forecast vs Benchmarks

TypeNameUpside
StockAC Immune SA240.91%
SectorHealthcare Stocks 25.20%
IndustryBiotech Stocks 63.35%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$8.00
Last Closing Price$2.64$2.64$2.64
Upside/Downside--203.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2513---4
Dec, 2413---4
Nov, 2423---5
Oct, 2433---6
Sep, 2433---6
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 30, 2024Thomas ShraderBTIG$8.00$3.97101.51%203.03%
Jul 11, 2022Leerink Partners$10.00$3.35198.51%278.79%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Sep 18, 2024H.C. WainwrightBuyBuyhold
May 30, 2024BTIGBuyinitialise
Jul 11, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-10 $-6 $-2 $2 $6 $10 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.86$-0.97$-0.85$-0.64-----
Avg Forecast$-0.83$-0.63$-0.88$-0.71$-0.54$-0.25$-0.24$0.62$0.85
High Forecast$-1.35$-1.03$-1.66$-0.78$-0.56$-2.75$-0.87$-7.66$-0.18
Low Forecast$-0.10$-0.08$-0.09$-0.63$-0.51$1.29$0.67$9.12$1.69
Surprise %3.61%53.97%-3.41%-9.86%-----

Revenue Forecast

$0 $80M $160M $240M $320M $400M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$15.43M-$3.94M$14.80M-----
Avg Forecast$15.63M$28.25M$5.58M$10.19M$27.09M$56.96M$66.35M$172.18M$201.19M
High Forecast$5.10M$9.22M$1.72M$9.35M$26.57M$3.86M$63.51M$11.66M$13.62M
Low Forecast$23.22M$41.99M$9.44M$11.04M$27.74M$100.42M$69.18M$303.54M$354.67M
Surprise %-1.25%--29.53%45.19%-----

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-62.10M$-73.00M$-70.75M$-54.23M-----
Avg Forecast$-69.92M$-53.55M$-74.13M$-59.72M$-45.51M$-24.87M$-24.29M$11.46M$71.67M
High Forecast$-114.11M$-87.40M$-140.66M$-65.87M$-47.67M$-232.52M$-74.05M$-648.74M$-15.19M
Low Forecast$-8.69M$-6.66M$-7.49M$-53.58M$-43.34M$109.58M$56.57M$772.66M$142.75M
Surprise %-11.18%36.30%-4.56%-9.19%-----

ACIU Forecast FAQ

Is AC Immune SA stock a buy?

AC Immune SA stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that AC Immune SA is a favorable investment for most analysts.

What is AC Immune SA's price target?

AC Immune SA's price target, set by 3 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $8 at the low end to $10 at the high end, suggesting a potential 240.91% change from the previous close price of $2.64.

How does AC Immune SA stock forecast compare to the average forecast of its sector, industry, and investment themes?

AC Immune SA stock forecast shows a 240.91% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the biotech stocks industry (63.35%).

What is the breakdown of analyst ratings for AC Immune SA over the past three months?

  • January 2025: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is AC Immune SA’s EPS forecast?

AC Immune SA's average annual EPS forecast for its fiscal year ending in December is -0.54 for 2024, a -15.62% decrease from the reported $-0.64 in 2023. The prediction for 2025 is $-0.25, $-0.24 for 2026, $0.62 for 2027, and $0.85 for 2028.

What is AC Immune SA’s revenue forecast?

AC Immune SA's average annual revenue forecast for its fiscal year ending in December is $27.09M for 2024, a 83.03% increase from the reported $14.8M in 2023. The forecast for 2025 is $56.96M, $66.35M for 2026, $172.18M for 2027, and $201.19M for 2028.

What is AC Immune SA’s net income forecast?

For its fiscal year ending in December, AC Immune SA's average annual net income forecast is $-45.506M for 2024, reflecting a -16.09% decrease from the reported $-54.233M in 2023. The projection for 2025 is $-24.874M, $-24.287M for 2026, $11.46M for 2027, and $71.67M for 2028.